Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
MERTK-targeted antibody-drug conjugate
DRUG CLASS:
MERTK-targeted antibody-drug conjugate
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
RGX-019 (6)
RGX-019-MMAE (3)
RGX-019 (6)
RGX-019-MMAE (3)
›
Associations
(9)
News
Trials
VERI cancer hierarchy
Reset Filters
MERTK expression
Non Small Cell Lung Cancer
MERTK expression
Non Small Cell Lung Cancer
RGX-019
Sensitive: D – Preclinical
RGX-019
Sensitive
:
D
RGX-019
Sensitive: D – Preclinical
RGX-019
Sensitive
:
D
MERTK expression
Breast Cancer
MERTK expression
Breast Cancer
RGX-019
Sensitive: D – Preclinical
RGX-019
Sensitive
:
D
RGX-019
Sensitive: D – Preclinical
RGX-019
Sensitive
:
D
MERTK expression
Melanoma
MERTK expression
Melanoma
RGX-019
Sensitive: D – Preclinical
RGX-019
Sensitive
:
D
RGX-019
Sensitive: D – Preclinical
RGX-019
Sensitive
:
D
MERTK expression
Multiple Myeloma
MERTK expression
Multiple Myeloma
RGX-019
Sensitive: D – Preclinical
RGX-019
Sensitive
:
D
RGX-019
Sensitive: D – Preclinical
RGX-019
Sensitive
:
D
MERTK expression
Triple Negative Breast Cancer
MERTK expression
Triple Negative Breast Cancer
RGX-019
Sensitive: D – Preclinical
RGX-019
Sensitive
:
D
RGX-019
Sensitive: D – Preclinical
RGX-019
Sensitive
:
D
MERTK expression
Acute Myelogenous Leukemia
MERTK expression
Acute Myelogenous Leukemia
RGX-019
Sensitive: D – Preclinical
RGX-019
Sensitive
:
D
RGX-019
Sensitive: D – Preclinical
RGX-019
Sensitive
:
D
MERTK expression
Multiple Myeloma
MERTK expression
Multiple Myeloma
RGX-019-MMAE
Sensitive: D – Preclinical
RGX-019-MMAE
Sensitive
:
D
RGX-019-MMAE
Sensitive: D – Preclinical
RGX-019-MMAE
Sensitive
:
D
MERTK expression
Acute Myelogenous Leukemia
MERTK expression
Acute Myelogenous Leukemia
RGX-019-MMAE
Sensitive: D – Preclinical
RGX-019-MMAE
Sensitive
:
D
RGX-019-MMAE
Sensitive: D – Preclinical
RGX-019-MMAE
Sensitive
:
D
MERTK expression
Triple Negative Breast Cancer
MERTK expression
Triple Negative Breast Cancer
RGX-019-MMAE
Sensitive: D – Preclinical
RGX-019-MMAE
Sensitive
:
D
RGX-019-MMAE
Sensitive: D – Preclinical
RGX-019-MMAE
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login